Migrevention
Developing a digital health solution to allow for remote treatment of migraine.
Migrevention has raised €355k across 1 funding round from 2 investors, most recently a Pre-Seed round in Jan 2022. Based in Tallinn, Estonia; active in Healthtech. Data as of 28 Oct 2026.
Tallinn, Estoniamigrevention.com ↗
Total raised
€355k
€355,000
Funding rounds
1
Investors
2
distinct backers
Active since
2022-01
latest 2022-01
Funding by year
EUR raised per yearMigrevention — funding by year — interactive chart.
Data table
| Migrevention — funding by year | |
|---|---|
| 2022 | €355k |
Signals
High confidenceRaise-next likelihood4
base rate 24% for Pre-Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-03 | Pre-Seed | €355k | Angel Investors,Dag Nurm | View deal → |
Investors
2Angel InvestorsDag Nurm
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bolt€1.8BEstonia · Transportation
- CMR Surgical€1.5BUK · Healthtech
- Wise€1.4BEstonia · Fintech
- Roivant Sciences€1.1BSwitzerland · Healthtech
Global coverage: FundingData